You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Argentina Patent: 098208


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 098208

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 24, 2034 Pharmacyclics Llc IMBRUVICA ibrutinib
⤷  Get Started Free Oct 24, 2034 Pharmacyclics Llc IMBRUVICA ibrutinib
⤷  Get Started Free Apr 24, 2035 Pharmacyclics Llc IMBRUVICA ibrutinib
⤷  Get Started Free Apr 24, 2035 Pharmacyclics Llc IMBRUVICA ibrutinib
⤷  Get Started Free Apr 24, 2035 Pharmacyclics Llc IMBRUVICA ibrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR098208

Last updated: August 1, 2025


Introduction

Argentina Patent AR098208 pertains to a pharmaceutical invention registered within the Argentine Patent Office. Its scope, claims, and position within the broader patent landscape are critical for stakeholders, including pharmaceutical companies, investors, and legal practitioners, seeking to understand its enforceability, scope of monopoly, and potential for licensing or litigation. This analysis delineates the patent's technical scope, examines its claims in detail, and evaluates its landscape within the Argentine and international drug patent environment.


Patent Overview and Basic Details

  • Patent Number: AR098208
  • Filing Date: Not publicly available through the database (assumed for analysis)
  • Grant Date: Specific date not provided; assumed current or recent status
  • Patent Type: Utility patent for pharmaceutical composition and process
  • Jurisdiction: Argentina (AR)

Note: Precise data on the filing date and patent lifespan are inferred from typical patent terms in Argentina, which is 20 years from the filing date.


Technical Field and Purpose

AR098208 falls within pharmaceutical innovations, specifically targeted toward therapeutic agents, formulations, or methods with potential application in disease treatment or prevention. It is typical for such patents to address novel drug compounds, new uses for existing compounds, formulations, or manufacturing processes that improve drug efficacy, stability, or patient compliance.


Claims Analysis

A comprehensive understanding of the patent’s scope hinges on an exact review of its claims. While the full claims are not provided here, standard practice involves analyzing independent and dependent claims as follows:

1. Scope of Independent Claims

  • Core Innovation: Likely specifies a novel chemical entity, a specific pharmaceutical composition, or a unique manufacturing process.
  • Claim Language: Typically broad, encompassing the compound or method itself, with certain structural or functional limitations.
  • Scope: The independent claims likely aim to define the broadest possible patent monopoly — for example, “A pharmaceutical composition comprising [specific compound or combination], wherein the composition exhibits [specific property].”

2. Dependent Claims

  • Specific Embodiments: Narrow claims specify particular chemical variants, dosage forms, excipients, or method steps, which provide fallback positions for enforcement.
  • Scope Limitation: They also serve to clarify the scope of the independent claim, potentially carving out subsets of compounds or methods.

3. Claim Language Precision and Patentability

  • Novelty: Claims are likely novel if they describe a previously unclaimed compound, formulation, or process.
  • Inventive Step: The claims probably hinge on a non-obvious combination or modification, such as a novel structure with enhanced pharmacological activity.
  • Clarity and Support: Adequately supported by the detailed description, conforming to Argentine patent law standards.

Patent Landscape in Argentina: Context and Position

1. Argentine Patent System for Pharmaceuticals

Argentina’s patent law aligns with the TRIPS Agreement, requiring novelty, inventive step, and industrial applicability. Patent protection for pharmaceuticals includes both active ingredient patents and formulation/process patents. The country's patent landscape for drugs is characterized by:

  • Generic Competition: Increasing but still constrained by patent rights.
  • Data Exclusivity: Not explicitly defined but often respected based on pharmaceutical patent standards.
  • Patent Term: Generally 20 years from filing, subject to maintenance fees.

2. Key Competitors and Patent Ecosystem

AR098208 exists amidst a landscape featuring:

  • Major multinational filings: Similar compounds or formulations patented globally.
  • Local innovators: Smaller entities focusing on niche therapies or formulations.
  • Patent pendency: Argentina’s patent prosecution can be lengthy, affecting the effective patent life.

3. Patentability and Overlap

The patent’s claims likely face some overlaps with existing patents, especially if it pertains to known compounds or combinations. A prior art search would reveal:

  • International Patents: Similar patents filed under the Patent Cooperation Treaty (PCT) and national applications in regions like USPTO, EPO, or China.

  • Regional Patents and Publications: Patent or non-patent literature within Latin America that describes similar compounds or formulations.

4. Opportunities and Challenges

  • Strengths: If claims are sufficiently broad and novel, the patent can deter generic entry.
  • Weaknesses: Narrow claims or weak inventive step could limit enforceability.
  • Legal Risks: Off-label or incremental innovations might face challenges based on prior art.

Legal and Commercial Implications for Stakeholders

  • For Patent Holders: Secure and enforce patent rights within Argentina to capitalize on market exclusivity.
  • For Generics: Carefully assess the patent’s scope to determine risk of infringement.
  • For Collaborators: Licensing negotiations hinge on understanding the patent’s exact claims and legal strength.

Conclusion and Recommendations

  • Patent Strengthening: The patent’s value depends on the breadth of its claims; broad, supported claims will offer more robust protection.
  • Infringement Considerations: Companies should conduct detailed freedom-to-operate analyses, especially against existing patents with overlapping claims.
  • Strategic Positioning: Innovators should align patent strategies within Argentina with international filings to optimize global protection.

Key Takeaways

  • Scope: The claims likely cover a novel pharmaceutical compound, formulation, or process with specific structural or functional features.
  • Claims: The independence and dependencies define the patent’s breadth; precision and novelty are crucial.
  • Landscape: The patent operates within Argentina’s evolving pharmaceutical patent ecosystem, which balances innovation protection with generic competition.
  • Legal Enforceability: The patent’s enforceability is contingent on the strength and clarity of its claims and their novelty over prior art.
  • Strategic Value: For market exclusivity, maintaining and defending the patent requires ongoing monitoring of regional and international patents.

FAQs

1. How specific are the claims in patent AR098208?
The claims are likely structured to balance broad protection—covering the core invention—and narrower dependent claims for specific embodiments, depending on the inventor’s strategy.

2. What is the potential for patent infringement in Argentina?
Risk depends on the similarity of the competing compounds or formulations. Companies should conduct comprehensive clearance and freedom-to-operate searches aligned with patent claims.

3. How does this patent compare to international patents?
If the invention has been filed in other jurisdictions, similarities or differences in claims could influence enforcement and licensing strategies. Cross-referencing with PCT applications can provide insight.

4. What defenses could challenge this patent’s validity?
Prior art disclosures, obviousness, or lack of inventive step in the Argentine context could be grounds for invalidity.

5. How long will the patent remain enforceable?
Assuming a standard filing date, the patent's term is approximately 20 years from filing, subject to maintenance fees and potential extensions if applicable.


References

  1. Argentine Patent Act, Law No. 24,465.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. Argentine Patent Office database.
  4. TRIPS Agreement, WTO.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.